Polygenic scores for low lung function and the future risk of adverse health outcomes
Abstract Aims Reduced lung function and adverse health outcomes are often observed. This study characterizes genetic susceptibility for reduced lung function and risk of developing a range of adverse health outcomes. Methods We studied 27,438 middle-aged adults from the Malmö Diet and Cancer study (...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-11-01
|
| Series: | Cardiovascular Diabetology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12933-022-01661-y |
| _version_ | 1828095055943958528 |
|---|---|
| author | Suneela Zaigham Isabel Gonçalves Regeneron Genetics Center Gunnar Engström Jiangming Sun |
| author_facet | Suneela Zaigham Isabel Gonçalves Regeneron Genetics Center Gunnar Engström Jiangming Sun |
| author_sort | Suneela Zaigham |
| collection | DOAJ |
| description | Abstract Aims Reduced lung function and adverse health outcomes are often observed. This study characterizes genetic susceptibility for reduced lung function and risk of developing a range of adverse health outcomes. Methods We studied 27,438 middle-aged adults from the Malmö Diet and Cancer study (MDCS), followed up to 28.8 years. Trait-specific Polygenic scores (PGS) for forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were constructed for each participant using MDCS genetic data and summary statistics from the latest GWAS of lung function. Linear regression models and cox proportional hazards regression models were used to assess associations between adverse health outcomes and lung function-PGS. Results FEV1-PGS and FVC-PGS were significantly associated with mean sBP at baseline after adjustments (FEV1-PGS Q1 (highest PGS = highest lung function): 140.7mmHg vs. Q4: 141.5mmHg, p-value 0.008). A low FVC-PGS was significantly associated with the risk of future diabetic events after adjustments (Q4 vs. Q1 HR: 1.22 (CI 1.12–1.32), p-trend < 0.001) and had added value to risk prediction models for diabetes. Low FEV1-PGS was significantly associated with future coronary events (Q4 vs. Q1 HR: 1.13 (CI: 1.04–1.22), p-trend 0.008). No significant association was found between PGS and sudden cardiac death, chronic kidney disease or all-cause mortality. Results remained largely unchanged in a subgroup of subjects when further adjusted for apolipoproteins. Conclusion Genetic susceptibility for reduced lung function is associated with higher sBP, increased risk of diabetes and to a lesser extent, future coronary events, suggesting etiological roles of lung function on these outcomes. Using PGS, high-risk groups could be early detected to implement early lifestyle changes to mitigate the risk. |
| first_indexed | 2024-04-11T07:06:38Z |
| format | Article |
| id | doaj.art-2f6e74984382411f8cb80ac633e8aa1f |
| institution | Directory Open Access Journal |
| issn | 1475-2840 |
| language | English |
| last_indexed | 2024-04-11T07:06:38Z |
| publishDate | 2022-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Cardiovascular Diabetology |
| spelling | doaj.art-2f6e74984382411f8cb80ac633e8aa1f2022-12-22T04:38:22ZengBMCCardiovascular Diabetology1475-28402022-11-0121111010.1186/s12933-022-01661-yPolygenic scores for low lung function and the future risk of adverse health outcomesSuneela Zaigham0Isabel Gonçalves1Regeneron Genetics Center2Gunnar Engström3Jiangming Sun4Department of Clinical Sciences Malmö, Lund UniversityDepartment of Clinical Sciences Malmö, Lund UniversityRegeneron Genetics CenterDepartment of Clinical Sciences Malmö, Lund UniversityDepartment of Clinical Sciences Malmö, Lund UniversityAbstract Aims Reduced lung function and adverse health outcomes are often observed. This study characterizes genetic susceptibility for reduced lung function and risk of developing a range of adverse health outcomes. Methods We studied 27,438 middle-aged adults from the Malmö Diet and Cancer study (MDCS), followed up to 28.8 years. Trait-specific Polygenic scores (PGS) for forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were constructed for each participant using MDCS genetic data and summary statistics from the latest GWAS of lung function. Linear regression models and cox proportional hazards regression models were used to assess associations between adverse health outcomes and lung function-PGS. Results FEV1-PGS and FVC-PGS were significantly associated with mean sBP at baseline after adjustments (FEV1-PGS Q1 (highest PGS = highest lung function): 140.7mmHg vs. Q4: 141.5mmHg, p-value 0.008). A low FVC-PGS was significantly associated with the risk of future diabetic events after adjustments (Q4 vs. Q1 HR: 1.22 (CI 1.12–1.32), p-trend < 0.001) and had added value to risk prediction models for diabetes. Low FEV1-PGS was significantly associated with future coronary events (Q4 vs. Q1 HR: 1.13 (CI: 1.04–1.22), p-trend 0.008). No significant association was found between PGS and sudden cardiac death, chronic kidney disease or all-cause mortality. Results remained largely unchanged in a subgroup of subjects when further adjusted for apolipoproteins. Conclusion Genetic susceptibility for reduced lung function is associated with higher sBP, increased risk of diabetes and to a lesser extent, future coronary events, suggesting etiological roles of lung function on these outcomes. Using PGS, high-risk groups could be early detected to implement early lifestyle changes to mitigate the risk.https://doi.org/10.1186/s12933-022-01661-yGenetic risk scoreLung functionDiabetesRisk prediction |
| spellingShingle | Suneela Zaigham Isabel Gonçalves Regeneron Genetics Center Gunnar Engström Jiangming Sun Polygenic scores for low lung function and the future risk of adverse health outcomes Cardiovascular Diabetology Genetic risk score Lung function Diabetes Risk prediction |
| title | Polygenic scores for low lung function and the future risk of adverse health outcomes |
| title_full | Polygenic scores for low lung function and the future risk of adverse health outcomes |
| title_fullStr | Polygenic scores for low lung function and the future risk of adverse health outcomes |
| title_full_unstemmed | Polygenic scores for low lung function and the future risk of adverse health outcomes |
| title_short | Polygenic scores for low lung function and the future risk of adverse health outcomes |
| title_sort | polygenic scores for low lung function and the future risk of adverse health outcomes |
| topic | Genetic risk score Lung function Diabetes Risk prediction |
| url | https://doi.org/10.1186/s12933-022-01661-y |
| work_keys_str_mv | AT suneelazaigham polygenicscoresforlowlungfunctionandthefutureriskofadversehealthoutcomes AT isabelgoncalves polygenicscoresforlowlungfunctionandthefutureriskofadversehealthoutcomes AT regenerongeneticscenter polygenicscoresforlowlungfunctionandthefutureriskofadversehealthoutcomes AT gunnarengstrom polygenicscoresforlowlungfunctionandthefutureriskofadversehealthoutcomes AT jiangmingsun polygenicscoresforlowlungfunctionandthefutureriskofadversehealthoutcomes |